Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 4561 AL 4575

Biomarkers in the Diagnosis and Prognosis of Alzheimer's Disease

Schaffer C, Sarad N, DeCrumpe A, Goswami D, Herrmann S, Morales J, Patel P, Osborne J.

J Lab Autom. 2015 Oct;20(5):589-600. doi: 10.1177/2211068214559979. Epub 2014 Nov 25.

Biomarkers, ketone bodies, and the prevention of Alzheimer's disease

VanItallie TB.

Metabolism. 2015 Mar;64(3 Suppl 1):S51-7. doi: 10.1016/j.metabol.2014.10.033. Epub 2014 Oct 30.

Biomarkers in the diagnosis and management of Alzheimer's disease

Wurtman R.

Metabolism. 2015 Mar;64(3 Suppl 1):S47-50. doi: 10.1016/j.metabol.2014.10.034. Epub 2014 Oct 30.

[Diagnosis and treatment of dementia: overview]

Furukawa K, Ishiki A, Tomita N, Arai H.

Rinsho Shinkeigaku. 2014;54(12):1171-3. doi: 10.5692/clinicalneurol.54.1171.

[Practice example: neurodegenerative disorders: randomised controlled multicentre trial of home-based occupational therapy for patients with dementia]

Voigt-Radloff S, Hüll M.

Z Evid Fortbild Qual Gesundhwes. 2013;107(3):222-8. doi: 10.1016/j.zefq.2013.04.001. Epub 2013 May 14.

MR, (18)F-FDG, and (18)F-AV45 PET correlate with AD PSEN1 original phenotype

Saint-Aubert L, Payoux P, Hannequin D, Barbeau EJ, Campion D, Delisle MB, Tafani M, Viallard G, Péran P, Puel M, Chollet F, Demonet JF, Pariente J.

Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):91-4. doi: 10.1097/WAD.0b013e318251d87c.

Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms

Hampel H.

J Alzheimers Dis. 2013;33 Suppl 1:S79-86. doi: 10.3233/JAD-2012-129003.

Imaging the onset and progression of Alzheimer's disease: implications for prevention trials

Liang Y, Ryan NS, Schott JM, Fox NC.

J Alzheimers Dis. 2013;33 Suppl 1:S305-12. doi: 10.3233/JAD-2012-129010.

Brain structural and functional connectivity and the progression of neuropathology in Alzheimer's disease

Matthews PM, Filippini N, Douaud G.

J Alzheimers Dis. 2013;33 Suppl 1:S163-72. doi: 10.3233/JAD-2012-129012.

Long night's journey into the day: amyloid-β imaging in Alzheimer's disease

Villemagne VL, Rowe CC.

J Alzheimers Dis. 2013;33 Suppl 1:S349-59. doi: 10.3233/JAD-2012-129034.

Rivastigmine patch ameliorates depression in mild AD: preliminary evidence from a 6-month open-label observational study

Spalletta G, Gianni W, Giubilei F, Casini AR, Sancesario G, Caltagirone C, Cravello L.

Alzheimer Dis Assoc Disord. 2013 Jul-Sep;27(3):289-91. doi: 10.1097/WAD.0b013e318260ab0a.

C145 as a short-latency electrophysiological index of cognitive compensation in Alzheimer's disease

Chapman RM, Porsteinsson AP, Gardner MN, Mapstone M, McCrary JW, Sandoval TC, Guillily MD, DeGrush E, Reilly LA.

J Alzheimers Dis. 2013;33(1):55-68. doi: 10.3233/JAD-2012-120646.

Enhancing the salience of fluency improves recognition memory performance in mild Alzheimer's disease

Bastin C, Willems S, Genon S, Salmon E.

J Alzheimers Dis. 2013;33(4):1033-9. doi: 10.3233/JAD-2012-121678.

Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline

Grundman M, Pontecorvo MJ, Salloway SP, Doraiswamy PM, Fleisher AS, Sadowsky CH, Nair AK, Siderowf A, Lu M, Arora AK, Agbulos A, Flitter ML, Krautkramer MJ, Sarsour K, Skovronsky DM, Mintun MA; 45-A17 Study Group.

Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):4-15. doi: 10.1097/WAD.0b013e318279d02a.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias